Clinical trial
ACVBP Followed by ASCT in Patients With BCL-2 Positive Diffuse Large B-Cell…
NCT00169130 · Lymphoma Study Association, Other · Completed
Key facts
| NCT number | NCT00169130 |
|---|---|
| Title | ACVBP Followed by ASCT in Patients With BCL-2 Positive Diffuse Large B-Cell Lymphoma |
| Official title | Prospective Study of ACVBP Followed by Autologous Stem Cell Transplantation in Case of BCL-2 Overexpression in Non Previously Treated Patients Aged 60 Years or Less With Low-Intermediate Risk Diffuse Large B-Cell Lymphoma |
| Lead sponsor | Lymphoma Study Association, Other |
| Collaborators | Fondation ARC |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Lymphoma, Large-Cell, Diffuse |
| Intervention type | Drug, Procedure |
| Interventions | doxorubicin, cyclophosphamide, Autologous stem cell transplantation |
| Enrollment | 300 |
| Start date | Oct 1, 1999 |
| First posted | Sep 15, 2005 |
| Last update posted | Jul 13, 2007 |
| Countries | Belgium, France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: